Search

Displaying results 8851 - 8860 of 10000 in total
  1. Drug

    Zifibancimig

    go.drugbank.com/drugs/DB19332
    Investigational

    Zifibancimig is under investigation in clinical trial NCT04567303, focusing on participants with neovascular age-related macular degeneration.

    Synonyms: Immunoglobulin G1 Fab fragment, bispecific, anti-(human vascular endothelial growth factor A and angiopoietin 2) (human monoclonal RO7250284 γ1-chain), disulfide with human monoclonal RO7250284 κ-chain, mmunoglobulin Fab G1-kappa, anti-[Homo sapiens ANGPT2 (angiopoietin 2, Ang2)] and anti-[Homo sapiens VEGFA (vascular endothelial growth factor A, VEGF-A, VEGF), monoclonal antibody, bispecific, biparatope
  2. Drug

    Mosliciguat

    go.drugbank.com/drugs/DB19425
    Investigational

    Mosliciguat is under investigation in clinical trial NCT06635850 (A Phase 2 Study of Mosliciguat in PH-ILD).

    Synonyms: (5s)-5-((2-(4-carboxyphenyl)ethyl)(2-(2-((3-chloro-4'-(trifluoromethyl)biphenyl-4-yl)methoxy)phenyl)ethyl)amino)-5,6,7,8-tetrahydroquinoline-2-carboxylic acid, 2-quinolinecarboxylic acid, 5-((2-(4-carboxyphenyl)ethyl)(2-(2-((3-chloro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methoxy)phenyl)ethyl)amino)-5,6,7,8-tetrahydro-, (5s)-
  3. Drug

    DT-DEC01

    go.drugbank.com/drugs/DB19433
    Experimental

    DT-DEC01 is a novel Dystrophin Expressing Chimeric (DEC) cell therapy being investigated by Dystrogen Therapeutics Corporation.

  4. Drug

    Sorbitan tristearate

    go.drugbank.com/drugs/DB20134
    Experimental

    Sorbitan tristearate is a small molecule drug. Sorbitan tristearate has a monoisotopic molecular weight of 962.85 Da.

  5. Drug

    Sorbitan monolaurate

    go.drugbank.com/drugs/DB20157
    Investigational

    Sorbitan monolaurate is a small molecule drug. Sorbitan monolaurate has a monoisotopic molecular weight of 346.24 Da.

    Categories: P-glycoprotein inhibitors
  6. Drug

    Simmerafil

    go.drugbank.com/drugs/DB22792
    Investigational

    Simmerafil is under investigation in clinical trial NCT06301854 (Long-term Safety of TPN171H Tablet in Erectile Dysfunction.).

  7. Drug

    Evobrutinib

    go.drugbank.com/drugs/DB15170
    Investigational

    Evobrutinib is under investigation in clinical trial NCT03934502 (Effect of Meal Composition and Timing on Evobrutinib Bioavailability).

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Tibric acid

    go.drugbank.com/drugs/DB20908
    Experimental

    Tibric acid is a small molecule drug. Tibric acid has a monoisotopic molecular weight of 331.06 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Iomeglamic acid

    go.drugbank.com/drugs/DB21167
    Experimental

    Iomeglamic acid is a small molecule drug. Iomeglamic acid has a monoisotopic molecular weight of 613.81 Da.

  10. Drug

    Kainic acid

    go.drugbank.com/drugs/DB21189
    Experimental

    Kainic acid is a small molecule drug. Kainic acid has a monoisotopic molecular weight of 213.1 Da.

    Categories: Heterocyclic Compounds, 1-Ring